Abbott Laboratories |
ABT |
🇺🇸 |
New York Stock Exchange |
$191.1bn |
S&P 100 S&P 500 S&P Global 100 |
Abbvie Inc |
ABBV |
🇺🇸 |
New York Stock Exchange |
$162.8bn |
S&P 500 |
Abcam |
ABC |
🇬🇧 |
London Stock Exchange |
£3.0bn |
|
Abiomed Inc. |
ABMD |
🇺🇸 |
NASDAQ |
$15.1bn |
S&P 500 |
Aflac Inc. |
AFL |
🇺🇸 |
New York Stock Exchange |
$38.2bn |
S&P 500 |
Alcon Inc. |
ALC |
🇨🇠|
SIX Swiss Exchange |
Fr.33.0bn |
STOXX600 |
Alexion Pharmaceuticals Inc. |
ALXN |
🇺🇸 |
NASDAQ |
$34.7bn |
NASDAQ 100 S&P 500 |
Align Technology, Inc. |
ALGN |
🇺🇸 |
NASDAQ |
$47.4bn |
S&P 500 |
Allergan plc |
AGN |
🇺🇸 |
New York Stock Exchange |
$60.7bn |
S&P 100 S&P 500 |
Alliance Pharma plc |
APH |
🇬🇧 |
London Stock Exchange |
£491mn |
|
Amerisource Bergen Corp. |
ABC |
🇺🇸 |
New York Stock Exchange |
$24.5bn |
S&P 500 |
AMGEN Inc. |
AMGN |
🇺🇸 |
NASDAQ |
$191.0bn |
S&P 100 NASDAQ 100 S&P 500 |
Animalcare Group Plc |
ANCR |
🇬🇧 |
London Stock Exchange |
£52mn |
|
Argen X SE |
ARGX |
🇧🇪 |
Euronext Brussels |
€0mn |
STOXX600 |
Astrazeneca plc |
AZN |
🇬🇧 |
London Stock Exchange |
£91.2bn |
FTSE 100 FTSE 350 FTSE Eurotop 100 S&P Global 100 CBOE 100 CBOE 350 OMX Stockholm 30 STOXX600 |
Bayer AG |
BAYN |
🇩🇪 |
Frankfurt Stock Exchange |
€44.1bn |
Euro Stoxx 50 DAX 30 FTSE Eurotop 100 S&P Global 100 TSIC Euro30 STOXX600 |
BB Biotech AG |
BION |
🇨🇠|
SIX Swiss Exchange |
Fr.4.4bn |
STOXX600 |
Becton, Dickinson And Co. |
BDX |
🇺🇸 |
New York Stock Exchange |
$66.9bn |
S&P 500 |
Biogen Inc |
BIIB |
🇺🇸 |
NASDAQ |
$63.4bn |
NASDAQ 100 S&P 500 |
Biomarin Pharmaceutical Inc. |
BMRN |
🇺🇸 |
NASDAQ |
$14.0bn |
|
Biomerieux |
BIM |
🇫🇷 |
Euronext Paris |
€13.2bn |
STOXX600 |
Boiron |
BOI |
🇫🇷 |
Euronext Paris |
€649mn |
|
Boston Scientific Corp. |
BSX |
🇺🇸 |
New York Stock Exchange |
$5.3bn |
S&P 500 |
Bristol-Myers Squibb Co. |
BMY |
🇺🇸 |
New York Stock Exchange |
$103.4bn |
S&P 100 S&P Global 100 S&P 500 |
Carl Zeiss Meditec A G |
AFX |
🇩🇪 |
Frankfurt Stock Exchange |
€12.5bn |
STOXX600 |
Celanese Corp - Ordinary Shares - Series A |
CE |
🇺🇸 |
New York Stock Exchange |
$19.3bn |
S&P 500 |
Celgene Corp. |
CELG |
🇺🇸 |
NASDAQ |
$46.2bn |
NASDAQ 100 S&P 500 |
Circassia Group Plc |
CIR |
🇬🇧 |
London Stock Exchange |
£83mn |
|
ConvaTec Group Plc |
CTEC |
🇬🇧 |
London Stock Exchange |
£3.9bn |
FTSE 250 FTSE 350 STOXX600 |
Dechra Pharmaceuticals plc |
DPH |
🇬🇧 |
London Stock Exchange |
£3.1bn |
FTSE 250 FTSE 350 CBOE 250 CBOE 350 STOXX600 |
Diasorin S.p.A. |
DIA |
🇮🇹 |
Italian Stock Exchange |
€7.8bn |
STOXX600 |
Eurofins Scientific S.E. |
ERF |
🇫🇷 |
Euronext Paris |
€1.5bn |
STOXX600 |
Evotec SE |
EVT |
🇩🇪 |
Frankfurt Stock Exchange |
€4.8bn |
STOXX600 |
Futura Medical |
FUM |
🇬🇧 |
London Stock Exchange |
£113mn |
|
Galapagos NV |
GLPG |
🇳🇱 |
Euronext Amsterdam |
€3.0bn |
STOXX600 BEL 20 AEX 25 |
Genmab |
GMAB |
🇩🇰 |
Copenhagen Stock Exchange |
kr.131.0bn |
STOXX600 |
Genus plc |
GNS |
🇬🇧 |
London Stock Exchange |
£3.1bn |
FTSE 250 FTSE 350 CBOE 250 CBOE 350 |
Gerresheimer AG |
GXI |
🇩🇪 |
Frankfurt Stock Exchange |
€2.7bn |
STOXX600 |
Getinge AB - Class B Shares |
GETI B |
🇸🇪 |
Stockholm Stock Exchange |
kr64.7bn |
STOXX600 |
Gilead Sciences, Inc. |
GILD |
🇺🇸 |
NASDAQ |
$49.3bn |
S&P 100 NASDAQ 100 S&P 500 |
Glaxosmithkline plc |
GSK |
🇬🇧 |
London Stock Exchange |
£64.0bn |
FTSE 100 FTSE 350 FTSE Eurotop 100 S&P Global 100 STOXX600 CBOE 100 CBOE 350 |
Grifols SA |
GRF |
🇪🇸 |
Barcelona Stock Exchange |
€3.9bn |
IBEX 35 STOXX600 |
Hikma Pharmaceuticals Plc |
HIK |
🇬🇧 |
London Stock Exchange |
£4.8bn |
FTSE 100 FTSE 350 CBOE 100 CBOE 350 STOXX600 |
H. Lundbeck AS |
LUN |
🇩🇰 |
Copenhagen Stock Exchange |
kr.44.5bn |
STOXX600 |
Hologic, Inc. |
HOLX |
🇺🇸 |
NASDAQ |
$19.7bn |
S&P 500 |
Illumina Inc |
ILMN |
🇺🇸 |
NASDAQ |
$49.8bn |
NASDAQ 100 S&P 500 |
Immunovant Inc |
IMVT |
🇺🇸 |
NASDAQ |
$1.4bn |
|
Incyte Corp. |
INCY |
🇺🇸 |
NASDAQ |
$17.1bn |
S&P 500 |
Indivior Plc |
INDV |
🇬🇧 |
London Stock Exchange |
£988mn |
CBOE 250 CBOE 350 |
Ipsen |
IPN |
🇫🇷 |
Euronext Paris |
€6.3bn |
STOXX600 |
Johnson & Johnson |
JNJ |
🇺🇸 |
New York Stock Exchange |
$444.6bn |
Dow Jones 30 S&P 100 S&P Global 100 BBC Global 30 S&P 500 |
Laboratory Corp. Of America Holdings |
LH |
🇺🇸 |
New York Stock Exchange |
$25.1bn |
S&P 500 |
Lilly(Eli) & Co |
LLY |
🇺🇸 |
New York Stock Exchange |
$214.1bn |
S&P 100 S&P 500 |
Lonza Group AG |
LONN |
🇨🇠|
SIX Swiss Exchange |
Fr.40.9bn |
STOXX600 |
Mckesson Corporation |
MCK |
🇺🇸 |
New York Stock Exchange |
$35.3bn |
S&P 500 |
Medtronic Plc |
MDT |
🇺🇸 |
New York Stock Exchange |
$124.5bn |
S&P 100 S&P 500 |
Merck & Co Inc |
MRK |
🇺🇸 |
New York Stock Exchange |
$232.4bn |
Dow Jones 30 S&P 100 S&P Global 100 S&P 500 |
Merck KGAA |
MRK |
🇩🇪 |
Frankfurt Stock Exchange |
€9.6bn |
DAX 30 STOXX600 |
Morphosys AG |
MOR |
🇩🇪 |
Frankfurt Stock Exchange |
€2.4bn |
STOXX600 |
Mylan N.V. |
MYL |
🇺🇸 |
NASDAQ |
$6.5bn |
NASDAQ 100 S&P 500 |
Nektar Therapeutics |
NKTR |
🇺🇸 |
NASDAQ |
$3.2bn |
S&P 500 |
Novartis AG - Ordinary Shares (Registered) |
NOVN |
🇨🇠|
SIX Swiss Exchange |
Fr.218.9bn |
FTSE Eurotop 100 S&P Global 100 BBC Global 30 STOXX600 |
Novo Nordisk - Class B Shares |
NOVO B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.881.5bn |
OMX Copenhagen 20 STOXX600 |
Novozymes AS - Class B Shares |
NZYM B |
🇩🇰 |
Copenhagen Stock Exchange |
kr.73.0bn |
STOXX600 OMX Copenhagen 20 |
OptiBiotix Health plc |
OPTI |
🇬🇧 |
London Stock Exchange |
£41mn |
|
Oxford BioDynamics Plc |
OBD |
🇬🇧 |
London Stock Exchange |
£84mn |
|
Oxford Biomedica |
OXB |
🇬🇧 |
London Stock Exchange |
£775mn |
FTSE 250 FTSE 350 |
Perrigo Company plc |
PRGO |
🇺🇸 |
New York Stock Exchange |
$5.5bn |
S&P 500 |
Pfizer Inc. |
PFE |
🇺🇸 |
New York Stock Exchange |
$273.4bn |
Dow Jones 30 S&P 100 S&P Global 100 S&P 500 |
Qiagen NV |
QGEN |
🇺🇸 |
New York Stock Exchange |
$12.0bn |
STOXX600 |
Recordati SpA |
REC |
🇮🇹 |
Italian Stock Exchange |
€9.5bn |
STOXX600 |
Regeneron Pharmaceuticals, Inc. |
REGN |
🇺🇸 |
NASDAQ |
$51.3bn |
S&P 500 |
Roche Holding AG |
ROG |
🇨🇠|
SIX Swiss Exchange |
Fr.49.5bn |
FTSE Eurotop 100 STOXX600 |
Sanofi |
SAN |
🇫🇷 |
Euronext Paris |
€113.0bn |
Euro Stoxx 50 CAC 40 FTSE Eurotop 100 S&P Global 100 Euronext 100 TSIC Euro30 STOXX600 |
Sartorius AG - Preference Share |
SRT3 |
🇩🇪 |
Frankfurt Stock Exchange |
€17.1bn |
STOXX600 |
Sartorius Stedim Biotech S.A. |
DIM |
🇫🇷 |
Euronext Paris |
€33.7bn |
STOXX600 |
Sativa Group Plc |
SATI |
🇬🇧 |
Nex Exchange |
£25mn |
|
Siemens Healthineers AG |
SHL |
🇩🇪 |
Frankfurt Stock Exchange |
€47.2bn |
STOXX600 |
Sonova Holding AG |
SOON |
🇨🇠|
SIX Swiss Exchange |
Fr.17.0bn |
STOXX600 |
Swedish Orphan Biovitrum AB |
SOBI |
🇸🇪 |
Stockholm Stock Exchange |
kr42.6bn |
STOXX600 |
Syncona Limited |
SYNC |
🇬🇧 |
London Stock Exchange |
£1.6bn |
FTSE 250 FTSE 350 |
Teleflex Incorporated |
TFX |
🇺🇸 |
New York Stock Exchange |
$19.7bn |
S&P 500 |
Teva- Pharmaceutical Industries Ltd. - ADR |
TEVA |
🇺🇸 |
New York Stock Exchange |
$7.4bn |
|
UCB SA |
UCB |
🇧🇪 |
Euronext Brussels |
€14.5bn |
BEL 20 Euronext 100 STOXX600 |
Vectura Group Plc |
VEC |
🇬🇧 |
London Stock Exchange |
£470mn |
CBOE 250 CBOE 350 |
Vertex Pharmaceuticals, Inc. |
VRTX |
🇺🇸 |
NASDAQ |
$46.3bn |
NASDAQ 100 S&P 500 |